CN Healthy Food Tech Faces Second Nasdaq Delisting Determination

The company says Nasdaq staff cited information from China's securities regulator and that its common stock and warrants remain under a trading halt.

Stock reaction: UCFI shares closed unchanged at $5.51 on Nov. 16, from Nov. 13's close of $5.51. The S&P 500 was down 1.9% that day.

Worker packing ripe red vine tomatoes on production line in a food processing plant
Photo: Juice Flair/Shutterstock.com

Key points

  • Nasdaq sent a second delisting determination dated Nov. 9, citing information from China's CSRC
  • The trading halt on the common stock and warrants remains in effect
  • The company may respond to the Panel in writing by Nov. 16, 2026
  • Q3 2026 revenue was $2.5 million, down 69%, with a net loss of $0.1 million

CN Healthy Food Tech Group Corp. (Nasdaq: UCFI) received a second delisting determination from Nasdaq, the company said in an 8-K filed Friday, Nov. 13. The notice follows an earlier Item 3.01 filing on Oct. 13, in which the company disclosed its original delisting notice, and it puts the company's common stock and warrants back before Nasdaq's Hearings Panel.

A Nasdaq letter dated Nov. 9 said the listing staff intends to issue an additional delisting determination under Listing Rule 5101 and for violating the rules on misrepresentation. The staff based that decision on information from the China Securities Regulatory Commission, including an Oct. 30 CSRC letter that the company says serves as an additional basis for delisting its common stock and its warrants, each exercisable for one share at $11.50.

What the regulator alleged

According to the filing, the Nasdaq letter describes CSRC allegations on several points: the company's compliance with CSRC filing requirements, the authenticity of certain materials it previously gave Nasdaq staff, its responsiveness to CSRC inquiries, and its PRC counsel. The 8-K does not describe the allegations in further detail, and the company does not address them in the filing.

Panel timeline and trading halt

The process began with a July 16 letter from Nasdaq's staff proposing to delist the securities. The company appealed, and on Oct. 7 the Panel allowed it to keep its listing subject to certain conditions. Trading was scheduled to resume Oct. 19. Instead, the staff continued the halt to request more information after receiving material from the CSRC. The trading halt remains in effect.

The company may give the Panel more information in writing by Nov. 16, 2026, and says it intends to present its views by that deadline. The Panel will weigh the new determination in deciding whether the company can continue to be listed on the Nasdaq Capital Market.

Recent financial results

The company's results for the last fiscal year, ended Dec. 31, 2025, showed revenue of $27.8 million, up 145% from a year earlier, and net income of $8.4 million, up 111%. Diluted earnings per share were $0.17, compared with $0.08.

For the quarter ended Sept. 30, 2026, revenue was $2.5 million, down 69% from a year earlier. Operating income was $0.4 million, down 91%. The company reported a net loss of $0.1 million, compared with net income of $3.3 million in the same quarter a year earlier. Diluted EPS was -$0.00, against $0.07. Cash and equivalents were $21.5 million as of Sept. 30. The 8-K itself does not discuss these results.

What happens next

The company says the Panel will rule on its continued listing, but the filing states there is no assurance the Panel will decide in its favor, or that the securities will resume trading or remain listed on Nasdaq. Zhenjun Jiang, chief executive officer and chairman, signed the report.

Sources

Written with AI from the company's SEC filing and our market data, and checked against those sources before publishing. Our editorial standards.

UCFI page →

Filings, figures and price history are on the CN Healthy Food Tech Group page.